Recognify Life Sciences
- Biotech or pharma, therapeutic R&D
Recognify Life Sciences is a clinical stage therapeutics company focused on impacting the quality of life of patients with central nervous system diseases and disorders through the enhancement of neuroplasticity. Our lead product RL-007 is currently being studied in a randomized placebo-controlled Phase 2b trial in CIAS (Cognitive Impairment Associated with Schizophrenia) patients to explore the cognitive and functional effects. Top-line readout is expected mid-2025 (Clinical Trail: NCT05686239).
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}